Wordt geladen...
Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow
Branched DNA (bDNA) assays to quantify human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) consist of three distinct steps, including sample processing, hybridization, and detection, and utilize the System 340 platform for plate incubation and washing. Sample processing differs:...
Bewaard in:
| Gepubliceerd in: | J Clin Microbiol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC446273/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15243070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.7.3120-3127.2004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|